Indivior PLC Notice of Results (8103O)
12 Octubre 2021 - 05:18AM
UK Regulatory
TIDMINDV
RNS Number : 8103O
Indivior PLC
12 October 2021
Indivior to Announce Q3 / 9 Months YTD 2021 Results and Host a
Presentation on October 28(th)
Slough, UK, and Richmond, VA, October 12, 2021 - Indivior PLC
(LON: INDV) today announced that it will release its Q3 / 9 months
YTD 2021 results on October 28(th) at 12:00 London time (7:00 a.m.
U.S. Eastern). The results will be available via the London Stock
Exchange's Regulatory News Service (RNS) and on the "Investors"
section of the company's website at www.indivior.com .
Mark Crossley, Chief Executive Officer, and other members of
Indivior's leadership team will host a conference call presentation
via a live webcast at 13:00 London time (8:00 a.m. U.S. Eastern) on
October 28(th) .
Access to the Live Webcast Presentation
The webcast event and materials can be accessed on the
"Investors" section of the company's website at www.indivior.com
before the event begins.
The webcast link is:
https://edge.media-server.com/mmc/p/oy28w6i3 .
Participants may access the presentation telephonically :
-- US participants 1-646-741-3167
-- International participants +44 (0) 2071-928338
-- Please reference confirmation ID 6677702. A replay of the presentation will be available at www.indivior.com .
About Indivior
Indivior is a global pharmaceutical company working to help
change patients' lives by developing medicines to treat addiction
and serious mental illnesses. Our vision is that all patients
around the world will have access to evidence-based treatment for
the chronic conditions and co-occurring disorders of addiction.
Indivior is dedicated to transforming addiction from a global human
crisis to a recognized and treated chronic disease.
Building on its global portfolio of opioid dependence
treatments, Indivior has a pipeline of product candidates designed
to both expand on its heritage in this category and potentially
address other chronic conditions and co-occurring disorders of
addiction, including alcohol use disorder. Headquartered in the
United States in Richmond, VA, Indivior employs more than 700
individuals globally and its portfolio of products is available in
over 40 countries worldwide. Visit www.indivior.com to learn more.
Connect with Indivior on LinkedIn by visiting
www.linkedin.com/company/indivior .
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-402-7123 or jason.thompson@indivior.com
###
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOREAEEAFFKFFFA
(END) Dow Jones Newswires
October 12, 2021 06:18 ET (10:18 GMT)
Indivior (LSE:INDV)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Indivior (LSE:INDV)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024